Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HNS 32

Known as: HNS-32 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
We report the well-designed active {1 1 0} and {1 1 1} faceted Cu2O hollow nanospheres (Cu2O-HNs) for the quick removal of the… Expand
2018
2018
Neurogenic inflammation plays a role in the pathophysiology of allergic rhinitis. Highly effective in reducing the sensory… Expand
2017
2017
BackgroundThe proportion of females enrolling into medical schools has been growing steadily. However, the representation of… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
2017
2017
The light absorption as well as the near field enhancements properties of Al@α-Fe2O3 core shell hybrid nanocylinders (HNs) have… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
국내외 해상 HNS 물동량이 증가하고 국내 해역에서 HNS 유출사고가 수차례 발생함에 따라, HNS 사고 대응 체계 강화에 대한 요구가 증가하고 있다. 특히 HNS… Expand
2004
2004
HNS-32 (N1,N1-dimethyl-N2-(2-pyridylmethyl)-5-isopropyl-3, 8-dimethylazulene-1-carboxamidine: CAS 186086-10-2) is a newly… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2002
2002
HNS-32, an azulene-1-carboxamidine derivative, is an originally synthesized antiarrhythmic compound. Its cardiovascular effects… Expand
  • figure 1
  • figure 2
  • figure 3
2001
2001
The electrophysiological and mechanical effects of HNS-32, a novel azulene-1-carboxamidine derivative with antiarrhythmic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2000
2000
Abstract. The vasorelaxant profile of a novel azulene-1-carboxamidine derivative, HNS-32 [N1,N1-dimethyl-N2-(2-pyridylmethyl)-5… Expand
  • table 1
  • figure 4
  • figure 6
  • figure 7
  • figure 8
2000
2000
The vasorelaxant actions of a novel azulene-1-carboxamidine derivative, HNS-32, were investigated on the tension development… Expand